- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Sustainability publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Expanding Opioid Receptor Pharmacology: From Pain Control to Novel Therapeutic Applications in Neurobiology, Immunology, and Psychiatry
Deadline: 30 April 2026
Biomarker, Phenotyping and Therapeutics for Asthma
Deadline: 30 April 2026
Epilepsy: From Mechanisms to Therapeutic Approaches (2nd Edition)
Deadline: 30 April 2026
Roles of Extracellular Vesicles in Health and Diseases
Deadline: 30 April 2026
Advances in Periodontal Disease and Systemic Disease
Deadline: 30 April 2026
The Role of Polyamines in Human Health and Disease—Second Edition
Deadline: 30 April 2026
Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (3rd Edition)
Deadline: 30 April 2026
Cancer Genetics: Bench-to-Bedside Advances
Deadline: 30 April 2026
State-of-the-Art Drug Discovery and Development in Poland (3rd Edition)
Deadline: 30 April 2026
Recent Advances in Cancer Metastasis Models
Deadline: 30 April 2026
Neuropathology: Understanding Local and Systemic Influence of Disease and Vice-Versa
Deadline: 30 April 2026
Selective Glucocorticoid Receptor Agonists and Modulators (SEGRAMs)
Deadline: 30 April 2026
of 148

